Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Jul 1;184(1):19–29. doi: 10.1084/jem.184.1.19

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

PMCID: PMC2192687  PMID: 8691133

Abstract

Human CD4+ T cells, activated by allogeneic monocytes in a primary mixed lymphocyte reaction in the presence of exogenous interleukin (IL) 10, specifically failed to proliferate after restimulation with the same alloantigens. A comparable state of T cell unresponsiveness could be induced by activation of CD4+ T cells by cross-linked anti-CD3 monoclonal antibodies (mAbs) in the presence of exogenous IL-10. The anergic T cells failed to produce IL-2, IL-5, IL-10, interferon gamma, tumor necrosis factor alpha, and granulocyte/macrophage colony- stimulating factor. The IL-10-induced anergic state was long-lasting. T cell anergy could not be reversed after restimulation of the cells with anti-CD3 and anti-CD28 mAbs, although CD3 and CD28 expression was normal. In addition, restimulation of anergized T cells with anti-CD3 mAbs induced normal Ca2+ fluxes and resulted in increased CD3, CD28, and class II major histocompatibility complex expression, indicating that calcineurin-mediated signaling occurs in these anergic cells. However, the expression of the IL-2 receptor alpha chain was not upregulated, which may account for the failure of exogenous IL-2 to reverse the anergic state. Interestingly, anergic T cells and their nonanergic counterparts showed comparable levels of proliferation and cytokine production after activation with phorbol myristate acetate and Ca2+ ionophore, indicating that a direct activation of a protein kinase C-dependent pathway can overcome the tolerizing effect of IL-10. Taken together, these data demonstrate that IL-10 induces T cell anergy and therefore may play an important role in the induction and maintenance of antigen-specific T cell tolerance.

Full Text

The Full Text of this article is available as a PDF (939.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bacchetta R., Bigler M., Touraine J. L., Parkman R., Tovo P. A., Abrams J., de Waal Malefyt R., de Vries J. E., Roncarolo M. G. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med. 1994 Feb 1;179(2):493–502. doi: 10.1084/jem.179.2.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bacchetta R., Parkman R., McMahon M., Weinberg K., Bigler M., de Vries J. E., Roncarolo M. G. Dysfunctional cytokine production by host-reactive T-cell clones isolated from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow. Blood. 1995 Apr 1;85(7):1944–1953. [PubMed] [Google Scholar]
  3. Bacchetta R., Vandekerckhove B. A., Touraine J. L., Bigler M., Martino S., Gebuhrer L., de Vries J. E., Spits H., Roncarolo M. G. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells. J Clin Invest. 1993 Mar;91(3):1067–1078. doi: 10.1172/JCI116264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bejarano M. T., de Waal Malefyt R., Abrams J. S., Bigler M., Bacchetta R., de Vries J. E., Roncarolo M. G. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol. 1992 Dec;4(12):1389–1397. doi: 10.1093/intimm/4.12.1389. [DOI] [PubMed] [Google Scholar]
  5. Bhandoola A., Cho E. A., Yui K., Saragovi H. U., Greene M. I., Quill H. Reduced CD3-mediated protein tyrosine phosphorylation in anergic CD4+ and CD8+ T cells. J Immunol. 1993 Sep 1;151(5):2355–2367. [PubMed] [Google Scholar]
  6. Boussiotis V. A., Freeman G. J., Griffin J. D., Gray G. S., Gribben J. G., Nadler L. M. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J Exp Med. 1994 Nov 1;180(5):1665–1673. doi: 10.1084/jem.180.5.1665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Caux C., Massacrier C., Vanbervliet B., Barthelemy C., Liu Y. J., Banchereau J. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol. 1994 Aug;6(8):1177–1185. doi: 10.1093/intimm/6.8.1177. [DOI] [PubMed] [Google Scholar]
  8. Chang C. H., Furue M., Tamaki K. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10. Eur J Immunol. 1995 Feb;25(2):394–398. doi: 10.1002/eji.1830250213. [DOI] [PubMed] [Google Scholar]
  9. Charlton B., Guymer R. H., Slattery R. M., Mandel T. E. Intercellular adhesion molecule (ICAM-1) inhibition can induce tolerance in vivo. Immunol Cell Biol. 1991 Apr;69(Pt 2):89–93. doi: 10.1038/icb.1991.14. [DOI] [PubMed] [Google Scholar]
  10. Dallman M. J., Wood K. J., Hamano K., Bushell A. R., Morris P. J., Wood M. J., Charlton H. M. Cytokines and peripheral tolerance to alloantigen. Immunol Rev. 1993 Jun;133:5–18. doi: 10.1111/j.1600-065x.1993.tb01507.x. [DOI] [PubMed] [Google Scholar]
  11. DeSilva D. R., Urdahl K. B., Jenkins M. K. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J Immunol. 1991 Nov 15;147(10):3261–3267. [PubMed] [Google Scholar]
  12. Ding L., Linsley P. S., Huang L. Y., Germain R. N., Shevach E. M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol. 1993 Aug 1;151(3):1224–1234. [PubMed] [Google Scholar]
  13. Ding L., Shevach E. M. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol. 1992 May 15;148(10):3133–3139. [PubMed] [Google Scholar]
  14. Fields P. E., Gajewski T. F., Fitch F. W. Blocked Ras activation in anergic CD4+ T cells. Science. 1996 Mar 1;271(5253):1276–1278. doi: 10.1126/science.271.5253.1276. [DOI] [PubMed] [Google Scholar]
  15. Groux H., Monte D., Plouvier B., Capron A., Ameisen J. C. CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-gamma and accessory cells. Eur J Immunol. 1993 Jul;23(7):1623–1629. doi: 10.1002/eji.1830230734. [DOI] [PubMed] [Google Scholar]
  16. Hervé P., Wijdenes J., Bergerat J. P., Bordigoni P., Milpied N., Cahn J. Y., Clément C., Béliard R., Morel-Fourrier B., Racadot E. Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) Blood. 1990 Feb 15;75(4):1017–1023. [PubMed] [Google Scholar]
  17. Jenkins M. K., Chen C. A., Jung G., Mueller D. L., Schwartz R. H. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol. 1990 Jan 1;144(1):16–22. [PubMed] [Google Scholar]
  18. Jenkins M. K. The role of cell division in the induction of clonal anergy. Immunol Today. 1992 Feb;13(2):69–73. doi: 10.1016/0167-5699(92)90137-V. [DOI] [PubMed] [Google Scholar]
  19. Kang S. M., Beverly B., Tran A. C., Brorson K., Schwartz R. H., Lenardo M. J. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science. 1992 Aug 21;257(5073):1134–1138. doi: 10.1126/science.257.5073.1134. [DOI] [PubMed] [Google Scholar]
  20. Lamb J. R., Skidmore B. J., Green N., Chiller J. M., Feldmann M. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med. 1983 May 1;157(5):1434–1447. doi: 10.1084/jem.157.5.1434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lenschow D. J., Bluestone J. A. T cell co-stimulation and in vivo tolerance. Curr Opin Immunol. 1993 Oct;5(5):747–752. doi: 10.1016/0952-7915(93)90132-c. [DOI] [PubMed] [Google Scholar]
  22. Li W., Whaley C. D., Mondino A., Mueller D. L. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science. 1996 Mar 1;271(5253):1272–1276. doi: 10.1126/science.271.5253.1272. [DOI] [PubMed] [Google Scholar]
  23. Linsley P. S., Wallace P. M., Johnson J., Gibson M. G., Greene J. L., Ledbetter J. A., Singh C., Tepper M. A. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science. 1992 Aug 7;257(5071):792–795. doi: 10.1126/science.1496399. [DOI] [PubMed] [Google Scholar]
  24. Macatonia S. E., Doherty T. M., Knight S. C., O'Garra A. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol. 1993 May 1;150(9):3755–3765. [PubMed] [Google Scholar]
  25. Miller G. T., Hochman P. S., Meier W., Tizard R., Bixler S. A., Rosa M. D., Wallner B. P. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses. J Exp Med. 1993 Jul 1;178(1):211–222. doi: 10.1084/jem.178.1.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nakao A., Nakajima H., Tomioka H., Nishimura T., Iwamoto I. Induction of T cell tolerance by pretreatment with anti-ICAM-1 and anti-lymphocyte function-associated antigen-1 antibodies prevents antigen-induced eosinophil recruitment into the mouse airways. J Immunol. 1994 Dec 15;153(12):5819–5825. [PubMed] [Google Scholar]
  27. Peçanha L. M., Snapper C. M., Lees A., Yamaguchi H., Mond J. J. IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. J Immunol. 1993 Apr 15;150(8 Pt 1):3215–3223. [PubMed] [Google Scholar]
  28. Punnonen J., Cocks B. G., de Vries J. E. IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells. Evidence for differential expression of functional IL-4 and IL-13 receptors during B cell ontogeny. J Immunol. 1995 Nov 1;155(9):4248–4254. [PubMed] [Google Scholar]
  29. Péguet-Navarro J., Moulon C., Caux C., Dalbiez-Gauthier C., Banchereau J., Schmitt D. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur J Immunol. 1994 Apr;24(4):884–891. doi: 10.1002/eji.1830240416. [DOI] [PubMed] [Google Scholar]
  30. Ramsdell F., Fowlkes B. J. Maintenance of in vivo tolerance by persistence of antigen. Science. 1992 Aug 21;257(5073):1130–1134. doi: 10.1126/science.257.5073.1130. [DOI] [PubMed] [Google Scholar]
  31. Roncarolo M. G., Yssel H., Touraine J. L., Betuel H., De Vries J. E., Spits H. Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera. J Exp Med. 1988 May 1;167(5):1523–1534. doi: 10.1084/jem.167.5.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Röcken M., Urban J. F., Shevach E. M. Infection breaks T-cell tolerance. Nature. 1992 Sep 3;359(6390):79–82. doi: 10.1038/359079a0. [DOI] [PubMed] [Google Scholar]
  33. Schwartz R. H. A cell culture model for T lymphocyte clonal anergy. Science. 1990 Jun 15;248(4961):1349–1356. doi: 10.1126/science.2113314. [DOI] [PubMed] [Google Scholar]
  34. Sloan-Lancaster J., Evavold B. D., Allen P. M. Th2 cell clonal anergy as a consequence of partial activation. J Exp Med. 1994 Oct 1;180(4):1195–1205. doi: 10.1084/jem.180.4.1195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Spits H., Keizer G., Borst J., Terhorst C., Hekman A., de Vries J. E. Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines. Hybridoma. 1983;2(4):423–437. doi: 10.1089/hyb.1983.2.423. [DOI] [PubMed] [Google Scholar]
  36. Suzuki G., Nomura M., Uzawa A., Akashi M., Nakata Y. Impaired CD28-mediated co-stimulation in anergic T cells. Int Immunol. 1995 Jan;7(1):37–43. doi: 10.1093/intimm/7.1.37. [DOI] [PubMed] [Google Scholar]
  37. Taga K., Mostowski H., Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood. 1993 Jun 1;81(11):2964–2971. [PubMed] [Google Scholar]
  38. Tivol E. A., Borriello F., Schweitzer A. N., Lynch W. P., Bluestone J. A., Sharpe A. H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995 Nov;3(5):541–547. doi: 10.1016/1074-7613(95)90125-6. [DOI] [PubMed] [Google Scholar]
  39. Willems F., Marchant A., Delville J. P., Gérard C., Delvaux A., Velu T., de Boer M., Goldman M. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol. 1994 Apr;24(4):1007–1009. doi: 10.1002/eji.1830240435. [DOI] [PubMed] [Google Scholar]
  40. Yssel H., De Vries J. E., Koken M., Van Blitterswijk W., Spits H. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J Immunol Methods. 1984 Aug 3;72(1):219–227. doi: 10.1016/0022-1759(84)90450-2. [DOI] [PubMed] [Google Scholar]
  41. Yssel H., De Waal Malefyt R., Roncarolo M. G., Abrams J. S., Lahesmaa R., Spits H., de Vries J. E. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol. 1992 Oct 1;149(7):2378–2384. [PubMed] [Google Scholar]
  42. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M. G., te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., de Vries J. E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 1991 Oct 1;174(4):915–924. doi: 10.1084/jem.174.4.915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. de Waal Malefyt R., Yssel H., de Vries J. E. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol. 1993 Jun 1;150(11):4754–4765. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES